These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 21929768)

  • 1. Stimulant reduction intervention using dosed exercise (STRIDE) - CTN 0037: study protocol for a randomized controlled trial.
    Trivedi MH; Greer TL; Grannemann BD; Church TS; Somoza E; Blair SN; Szapocznik J; Stoutenberg M; Rethorst C; Warden D; Ring KM; Walker R; Morris DW; Kosinski AS; Kyle T; Marcus B; Crowell B; Oden N; Nunes E
    Trials; 2011 Sep; 12():206. PubMed ID: 21929768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale for Using Exercise in the Treatment of Stimulant Use Disorders.
    Greer TL; Ring KM; Warden D; Grannemann BD; Church TS; Somoza E; Blair SN; Szapocznik J; Stoutenberg M; Rethorst C; Walker R; Morris DW; Kosinski AS; Kyle T; Marcus B; Crowell B; Oden N; Nunes E; Trivedi MH
    J Glob Drug Policy Pract; 2012; 6(1):. PubMed ID: 25364477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and long-term cannabis use among stimulant users: Results from CTN-0037 Stimulant Reduction Intervention using Dosed Exercise (STRIDE) Randomized Control Trial.
    Vidot DC; Rethorst CD; Carmody TJ; Stoutenberg M; Walker R; Greer TL; Trivedi MH
    Drug Alcohol Depend; 2019 Jul; 200():139-144. PubMed ID: 31129484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized Controlled Trial Comparing Exercise to Health Education for Stimulant Use Disorder: Results From the CTN-0037 STimulant Reduction Intervention Using Dosed Exercise (STRIDE) Study.
    Trivedi MH; Greer TL; Rethorst CD; Carmody T; Grannemann BD; Walker R; Warden D; Shores-Wilson K; Stoutenberg M; Oden N; Silverstein M; Hodgkins C; Love L; Seamans C; Stotts A; Causey T; Szucs-Reed RP; Rinaldi P; Myrick H; Straus M; Liu D; Lindblad R; Church T; Blair SN; Nunes EV
    J Clin Psychiatry; 2017; 78(8):1075-1082. PubMed ID: 28199070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometrics of the Self-Report Concise Associated Symptoms Tracking Scale (CAST-SR): Results From the STRIDE (CTN-0037) Study.
    Trombello JM; Killian MO; Liao A; Sanchez K; Greer TL; Walker R; Grannemann B; Rethorst CD; Carmody T; Trivedi MH
    J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29325238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of vigorous-intensity exercise as an aid to smoking cessation in adults with elevated anxiety sensitivity: study protocol for a randomized controlled trial.
    Smits JA; Zvolensky MJ; Rosenfield D; Marcus BH; Church TS; Frierson GM; Powers MB; Otto MW; Davis ML; DeBoer LB; Briceno NF
    Trials; 2012 Nov; 13():207. PubMed ID: 23148822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying and responding to trial implementation challenges during multisite clinical trials.
    Greer TL; Walker R; Rethorst CD; Northrup TF; Warden D; Horigian VE; Silverstein M; Shores-Wilson K; Stotts AL; Trivedi MH
    J Subst Abuse Treat; 2020 Mar; 112S():63-72. PubMed ID: 32220413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial relationship status and quality as predictors of exercise intervention adherence and substance use outcomes: Results from the STRIDE (CTN-0037) study.
    Trombello JM; Carmody T; Greer TL; Walker R; Rethorst CD; Trivedi MH
    Psychiatry Res; 2017 Aug; 254():332-339. PubMed ID: 28525788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender and racial/ethnic differences in physiologic responses in the Stimulant Reduction Intervention using Dosed Exercise Study.
    Killeen TK; Wolf B; Greer TL; Carmody T; Rethorst CD; Trivedi MH
    Addict Behav; 2020 Nov; 110():106546. PubMed ID: 32688225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial and ethnic differences in treatment outcomes among adults with stimulant use disorders after a dosed exercise intervention.
    Sanchez K; Greer TL; Walker R; Carmody T; Rethorst CD; Trivedi MH
    J Ethn Subst Abuse; 2017; 16(4):495-510. PubMed ID: 28524806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulant abuser groups to engage in 12-step: a multisite trial in the National Institute on Drug Abuse Clinical Trials Network.
    Donovan DM; Daley DC; Brigham GS; Hodgkins CC; Perl HI; Garrett SB; Doyle SR; Floyd AS; Knox PC; Botero C; Kelly TM; Killeen TK; Hayes C; Kau'i Baumhofer N; Seamans C; Zammarelli L
    J Subst Abuse Treat; 2013 Jan; 44(1):103-14. PubMed ID: 22657748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research staff training in a multisite randomized clinical trial: Methods and recommendations from the Stimulant Reduction Intervention using Dosed Exercise (STRIDE) trial.
    Walker R; Morris DW; Greer TL; Trivedi MH
    Addict Res Theory; 2014; 22(5):407-415. PubMed ID: 25379036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ounce of prevention: A pre-randomization protocol to improve retention in substance use disorder clinical trials.
    Northrup TF; Greer TL; Walker R; Rethorst CD; Warden D; Stotts AL; Trivedi MH
    Addict Behav; 2017 Jan; 64():137-142. PubMed ID: 27610591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and methods for site selection for a trial using a novel intervention to treat stimulant abuse.
    Warden D; Trivedi MH; Greer TL; Nunes E; Grannemann BD; Horigian VE; Somoza E; Ring K; Kyle T; Szapocznik J
    Contemp Clin Trials; 2012 Jan; 33(1):29-37. PubMed ID: 21946515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the primary endpoint for a stimulant abuse trial: lessons learned from STRIDE (CTN 0037).
    Trivedi MH; Greer TL; Potter JS; Grannemann BD; Nunes EV; Rethorst C; Warden D; Ring KM; Somoza E
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):339-49. PubMed ID: 21854276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Complier Average Causal Effect Analysis of the Stimulant Reduction Intervention using Dosed Exercise Study.
    Carmody T; Greer TL; Walker R; Rethorst CD; Trivedi MH
    Contemp Clin Trials Commun; 2018 Jun; 10():1-8. PubMed ID: 29682627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline medical comorbidities in adults randomized in the STRIDE trial for psychostimulant use disorders.
    Dela Cruz AM; Carmody T; Greer TL; Rethorst CD; Warden D; Walker R; Trivedi MH
    Am J Addict; 2016 Apr; 25(3):215-20. PubMed ID: 26991889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality assurance of research protocols conducted in the community: the National Institute on Drug Abuse Clinical Trials Network experience.
    Rosa C; Campbell A; Kleppinger C; Sampson R; Tyson C; Mamay-Gentilin S
    Clin Trials; 2009 Apr; 6(2):151-61. PubMed ID: 19342468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does an 8-week home-based exercise program affect physical capacity, quality of life, sick leave, and use of psychotropic drugs in patients with pulmonary embolism? Study protocol for a multicenter randomized clinical trial.
    Rolving N; Brocki BC; Mikkelsen HR; Ravn P; Bloch-Nielsen JR; Frost L
    Trials; 2017 May; 18(1):245. PubMed ID: 28558825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.